XML 95 R12.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Investments
12 Months Ended
Dec. 31, 2019
Investments, Debt and Equity Securities [Abstract]  
Investments
NOTE 6. INVESTMENTS

The following tables summarize the Company’s available-for-sale investments at December 31 (in thousands):

AVAILABLE-FOR-SALE INVESTMENTS
2019
(in thousands)
 
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
Certificates of deposit
$
5,646

$
17

$

$
5,663

US Treasury securities
12,564

16

(1
)
12,579

US Agency securities
4,002


(4
)
3,998

Commercial paper
2,492


(1
)
2,491

Corporate notes and bonds
22,711

6

(11
)
22,706

Total
$
47,415

$
39

$
(17
)
$
47,437


AVAILABLE-FOR-SALE INVESTMENTS
2018
(in thousands)
 
Amortized Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
Certificates of deposit
$
10,787

$

$

$
10,787

US Treasury securities
22,185

1

(66
)
22,120

US Agency securities
8,024

1

(45
)
7,980

Commercial paper
17,025



17,025

Asset-backed securities
12,007


(9
)
11,998

Corporate notes and bonds
30,361


(53
)
30,308

Total
$
100,389

$
2

$
(173
)
$
100,218



The following table summarizes the maturities of the Company’s available-for-sale securities at December 31 (in thousands):

AVAILABLE-FOR-SALE INVESTMENT MATURITIES
(in thousands)
 
2019
2018
 
Amortized
Cost
Fair Value
Amortized
Cost
Fair Value
Due in less than 1 year
$
43,627

$
43,650

$
83,030

$
82,893

Due in 1-5 years
3,788

3,787

17,359

17,325

Total
$
47,415

$
47,437

$
100,389

$
100,218



Proceeds from sales of marketable securities (including principal paydowns) for the years ended December 31, 2019 and 2018 were $14.5 million and $3.0 million, respectively. The Company determines gains and losses of marketable securities based on specific identification of the securities sold. There were no material realized gains or losses from sales of marketable securities for the years ended December 31, 2019, 2018 and 2017. No material balances were reclassified out of accumulated other comprehensive loss for the years ended December 31, 2019, 2018 and 2017.

The Company monitors investments for other-than-temporary impairment. It was determined that unrealized gains and losses as of December 31, 2019 and 2018 are temporary in nature because the change in market value for those securities has resulted from fluctuating interest rates rather than a deterioration of the credit worthiness of the issuers. The Company does not intend to sell these investments and it is more likely than not that we will not be required to sell investments before recovering the amortized cost.

Additional information regarding the fair value of our financial instruments is included in Note 5, Fair Value of Financial Instruments.